“SGLT2 Inhibitor Safety Signals in FAERS Ketoacidosis and Other Adverse Events across 154,476 Spontaneous Reports”. Diabzen 4, no. 16 (July 7, 2026): 32–33. Accessed September 17, 2026. https://www.thediabzen.com/index.php/d/article/view/59.